Thursday, April 25, 2024

Advertisement

Updated on: April 29, 2020 20:40 IST

Clinical trial started at PGIMER Chandigarh to position Sepsivac as drug for COVID-19 treatment: CSIR-IIIM Director

CSIR-IIIM Director and coordinator of trial programme for use of Sepsivac in COVID-19 treatment, Dr. Ram Vishwakarma said that Clinical trial has begun at PGIMER Chandigarh to position immunomodulator Sepsivac as a drug.

Next Video

Superfast 200: Watch 200 big news of April 10, 2023 of the country and world in a flash
Amid the Covid-19 case rise, nationwide mock drill starts from today to check covid preparedness
Super 100: Watch 100 big news of April 10, 2023 of the country and world in a flash

Latest Videos

Aaj Ki Baat→

Aap Ki Adalat→

Sports→

Oh My God→

Kurukshetra→

Entertainment→

Advertisement

Recommended Video

Advertisement

Top News

Advertisement

Latest News

Advertisement